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Background: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that mediates
eosinophilic differentiation, migration and survival, causing respiratory tract inﬂammation. GM-CSF is
also known to be secreted from respiratory tract structural cells. However, the mechanisms of GM-CSF
secretion have not been well established.
Methods: Human fetal lung ﬁbroblasts and human primary asthmatic lung ﬁbroblasts were used for the
study of tumor necrosis factor alpha (TNF-a)-induced GM-CSF secretion. GM-CSF secretion and mRNA
expression were measured by enzyme-linked immunosorbent assay and quantitative real-time reverse
transcription polymerase chain reaction, respectively. Knockdown of cAMP response element-binding
protein (CREB) in ﬁbroblasts was carried out by using speciﬁc small interfering RNAs of CREB.
Results: Among respiratory tract structural cells, pulmonary ﬁbroblasts exhibited increased GM-CSF
secretion and mRNA expression after stimulation with TNF-a in a concentration-dependent manner.
Moreover, a p38 mitogen-activated protein kinase (MAPK) inhibitor controlled TNF-a-induced GM-CSF
secretion, and roﬂumilast and rolipram, inhibitors of phosphodiesterase-4, suppressed TNF-a-induced
GM-CSF secretion. Consistent with this, forskolin also completely blocked GM-CSF secretion, and similar
results were observed in response to cAMP treatment, suggesting that cAMP signaling suppressed TNF-a-
induced GM-CSF secretion in human lung ﬁbroblasts. Furthermore, CREB was phosphorylated through
p38 MAPK but not cAMP signaling after TNF-a stimulation, and GM-CSF secretion was inhibited by CREB
knockdown. Finally, these effects were also demonstrated in human primary lung ﬁbroblasts in a patient
with asthma.
Conclusions: CREB signaled independent of cAMP signaling and was phosphorylated by p38 MAPK
following TNF-a stimulation, playing a critical role in GM-CSF secretion in human lung ﬁbroblasts.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).nd Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Sho-wa Machi Maebashi, Gunma
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Asthma is a type of allergic inﬂammation of the airways.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is
thought to have a central role in the pathogenesis of asthma,
which is characterized by eosinophilic inﬂammation of the
bronchi.1 Although the pathogenesis of allergic inﬂammation is
complicated, GM-CSF, which exhibits chemotactic activity in eo-
sinophils, has been shown to play a pivotal role in allergic
inﬂammation through the recruitment of eosinophils to the site of
allergic inﬂammation.2e4 GM-CSF is essential for the maintenance
of eosinophil activity, including eosinophil differentiation,
migration, and survival, and is known to be secreted from bron-
chial epithelium cells (BECs), respiratory tract ﬁbroblasts, and
airway smooth muscle cells (ASMCs).5e7 The mechanisms of GM-
CSF secretion have been investigated mainly using BECs,8e10 but
not lung ﬁbroblasts. In asthma, damage and detachment of the
bronchial epithelium are observed. A similar state is worsened by
the respiratory viral infection, and it is thought that lung ﬁbro-
blasts and ASMc under BECs in asthma produce various cytokines
because it is exposed to various inﬂammatory mediators. There-
fore, examining inﬂammatory cytokine secretion from lung ﬁ-
broblasts was important for understanding asthmatic airway
inﬂammation.
GM-CSF hypersecretion is associatedwith various pathologies of
the respiratory tract, such as airway remodeling, chronic inﬂam-
mation, and airway hypersensitivities,11,12 and p38 mitogen-
activated protein kinase (MAPK) has been shown to be important
for GM-CSF secretion10 as well as inﬂammation, cell cycle pro-
gression, differentiation, and apoptosis.13 p38 MAPK activity is
induced by a variety of extracellular stimuli, such as pro-
inﬂammatory cytokines, tumor necrosis factor alpha (TNF-a).14
However, the underlying mechanism through which p38 MAPK
regulates GM-CSF secretion is unknown.
Many transcriptional effects of cAMP are mediated by the
cAMP response element-binding (CREB) protein.15e17 CREB regu-
lates several cellular functions, such as inﬂammation, cell prolif-
eration, differentiation, adaptation, and survival.18,19 Increased
CREB activity has been shown to be associated with the patho-
genesis of asthma, alterations in cognitive memory, and the
development of chronic obstructive pulmonary disease
(COPD).20e22 Although CREB phosphorylation at serine 133 is
signiﬁcantly increased in the epithelium and submucosa in pa-
tients with asthma,20 little is known about the in vitro mecha-
nisms mediating the association between CREB phosphorylation
and asthma.
Tumor necrosis factor alpha (TNF-a) stimulation has been
shown to increase CREB phosphorylation through activation of the
p38 MAPK pathway in human umbilical vein endothelial cells,23
vascular smooth muscle cells,24 and vascular endothelial cells.25
Other signaling pathways that lead to the phosphorylation of
CREB include the calcium/calmodulin kinase pathway,26 extracel-
lular signal-regulated kinase (ERK) activation,27 protein kinase C
(PKC),28 and phosphatidylinositol 3-kinase (PI3-K).29 However, the
physiological signiﬁcance of CREB phosphorylation in airway
structural cells has not been investigated.
In this study, we compared the levels of TNF-a-induced GM-CSF
secretion using airway structural cells and found that GM-CSF was
secreted from lung ﬁbroblasts as well as BECs; thus, we investigated
the mechanism of TNF-a-induced GM-CSF secretion from lung ﬁ-
broblasts. This is the ﬁrst report showing the involvement of CREB
in GM-CSF secretion.Methods
Reagents
SB239063, SP600125, and Roﬂumilast were purchased from
SigmaeAldrich (St. Louis, MO, USA). Forskolin, LY294002, Rolipram,
and PD98059 were purchased from WAKO Biochemical (Osaka,
Japan). TNF-a was purchased from PeproTech (Rocky Hill, NJ, USA).
Cell-permeable 8-bromo-cAMP was purchased from Cayman
Chemical (Ann Arbor, MI, USA). SB239063, SP600125, Roﬂumilast,
forskolin, LY294002, Rolipram and PD98059 were dissolved in
dimethyl sulfoxide (DMSO). Unless otherwise stated, the cells were
incubated with these agents or their vehicle under starvation
conditions at 37 C in an atmosphere containing 5% CO2 and 95% air.
Cell culture
Human fetal lung ﬁbroblasts (HFL-1 cells; lung, diploid, human)
and human bronchial epithelial cells (Beas-2B) were obtained from
the American Type Culture Collection (Rockville, MD, USA). Human
ASMCs and human primary asthmatic lung ﬁbroblasts (AHLFs)
were purchased from Lonza (Walkersville, MD, USA). In all exper-
iments, cells were used between passages 2 and 8 and cultured in a
humidiﬁed atmosphere of 95% air plus 5% CO2. HFL-1 cells were
cultured in F-12 medium (Invitrogen, Grand Island, NY, USA) con-
taining 10% FBS (Biological Industries, Israel).30 Beas-2B cells were
cultured in bronchial epithelial cell basal medium (Lonza, Wal-
kersville, MD, USA) supplemented with bovine pituitary extracts,
hydrocortisone, epidermal growth factor, epinephrine, transferrin,
insulin, retinoic acid and triiodothyonine.31 Before each experi-
ment, Beas-2B cells were starved with DMEM (SigmaeAldrich)
supplemented with 0.1% fatty acid-free BSA. Human ASMCs were
grown in Lonza custom smooth muscle growth media supple-
mented with human epidermal growth factor, insulin, human
ﬁbroblast growth factor b, and FBS.32 AHLFs were grown in Lonza
custom ﬁbroblast basal media-2 medium with additional Lonza
SingleQuots supplements containing insulin, recombinant ﬁbro-
blast growth factor-b, and FBS.
Antibodies
Primary antibodies selectively recognizing phosphorylated
forms of c-Jun N-terminal kinase (JNK; anti-phospho-JNK, Thr183/
Tyr185), p38 MAPK (anti phospho-p38 MAPK, Thr180/Tyr182), ERK
(anti phospho-p44/42 MAPK, Thr202/Tyr204), AKT (anti-phopho-
AKT, Ser473, Thr308), CREB (anti-phospho-CREB, Ser133) were
purchased from Cell Signaling Technology (Beverly, MA, USA).
Phosphorylation-state independent anti-JNK, anti-p38 MAPK, anti-
ERK, anti-b-actin, and anti-CREB antibodies were also purchased
from Cell Signaling Technology.
Enzyme-linked immunosorbent assay (ELISA)
TNF-a-induced secretion of GM-CSF and interleukin (IL)-8 in the
supernatant was quantiﬁed by ELISA using a DuoSet ELISA Devel-
opment System (R&D Systems, Minneapolis, MN, USA) according to
themanufacturer's instructions. Cells were seeded in 12-well plates
and cultured in complete medium for 36e48 h and then starved for
24 h. The cells were stimulated with 10 ng/mL TNF-a in the pres-
ence or absence of various inhibitors. Lower detection limit of ELISA
for GM-CSF and IL-8 were approximately 10 pg/mL and 20 pg/mL,
respectively.
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Cells were stimulated with TNF-a for 12 h, and mRNA was
extracted and puriﬁed using an RNeasy Mini kit (Qiagen, Hilden,
Germany). The mRNAs were treated with DNase (Qiagen) and
converted to cDNA using a high-capacity cDNA archive kit (Applied
Biosystems, Foster City, CA, USA).Quantitative RT-PCR (RT-qPCR)
TaqMan probes for RT-qPCR were purchased from Applied Bio-
systems. The mRNA expression levels of human GM-CSF and glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH) were measured
by RT-qPCR using TaqMan gene expression assays on a sequence
detection system model 7700 (Applied Biosystems). All data were
standardized to GAPDH as previously described.33Transfection with small interfering RNA (siRNA)
Nonsilencing control siRNA (AATTCTCCGAACGTGTCACGT) and
siRNAs targeting CREB, i.e., CREB#4 (CAGCCACAGATTGCCACATTA),
CREB#5 (AACCAAGTTGTTGTTCAAGCT)34,35 and CREB#6 (AACT-
GATTCCCAAAAGCGAAG)35 were purchased from Qiagen. siRNA
transfections were carried out by reverse transfection according to
the manufacturer's protocol (Invitrogen).32 Brieﬂy, siRNA (2.0 nM
for HFL-1 and 0.5 nM for AHFL) was incubated with RNAiMAX re-
agent (Invitrogen) in Opti-MEM (GIBCO) for 15e30 min, mixed
with the cells suspended in F-12 medium supplemented with 10%
FBS, and then cultured in 6- or 12-well plates. After incubation for
36e48 h, the cells were starved with culture medium supple-
mented with fatty acid-free BSA without FBS and incubated for the
indicated times.Fig. 1. TNF-a-induced GM-CSF secretion from respiratory tract structural cells. (A) TNF-a-ind
for 24 h prior to TNF-a stimulation. The cells were incubated with 10 ng/mL TNF-a for 24
expression induced by TNF-a in respiratory tract structural cells. The cells were treated as in (
CSF mRNA expression after TNF-a stimulation divided by the GAPDH mRNA expression
Concentration-dependent effects of TNF-a-induced GM-CSF secretion from HFL-1 cells. Ce
centrations. The supernatants were centrifuged and subjected to GM-CSF ELISA. * P < 0.05Western blotting
Cells were incubated with 10% trichloroacetic acid for 10 min,
and the physiological reactions in the cells were then terminated.
The cells were washed with 1 phosphate-buffered saline once
and with water once to remove trichloroacetic acid. The cells
were then lysed using 2 SDS sampling buffer (40 mM Tris-HCl,
pH 6.8, 1.6% SDS, 0.016% bromophenol blue, 24% glycerol). Cell
lysates were separated by SDS-polyacrylamide gel electropho-
resis using 5e20% gradient gels (Wako Chemicals, Tokyo, Japan)
at 100 V. Proteins in the gels were transferred to nitrocellulose
membranes, which were subsequently blocked with blocking
buffer (50 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, and 5%
dried milk powder) for 60 min. Membranes were incubated with
primary antibodies overnight at 4 C. After ﬁve washes for 5 min
each, membranes were incubated with horseradish peroxidase-
labeled secondary antibodies (1:3000 in blocking buffer) for
60 min at room temperature, followed by another nine washes
for 5 min each. Signal detection was carried out using Supersignal
West Pico Chemiluminescent Substrate (ThermoFisher Scientiﬁc,
MA, USA).Cell proliferation assay
The effects of CREB siRNA on cell proliferation were evaluated
using a Cell Counting Kit-8 (Dojindo Laboratories, Kumamoto,
Japan) according to the manufacturer's protocol. The cells treated
with siRNA were incubated at a density of 2  104 cells per well in
96-well plates. Next, cells were incubated for 72 h and the Cell
Counting Kit-8 reagents (10 mL) were added to the medium. The
cells were further incubated for 2 h, and the absorbance at 450 nm,
which reﬂected the amount of formazan dye generated by activeuced GM-CSF secretion from the respiratory tract structural cells. The cells were starved
h. GM-CSF levels in the supernatants were analyzed using ELISAs. (B) GM-CSF mRNA
A) and then harvested for mRNA puriﬁcation. The y-axis shows the relative ratio of GM-
. (C) Time-dependence of TNF-a-induced GM-CSF secretion from HFL-1 cells. (D)
lls were starved for 24 h and stimulated with TNF-a at the indicated times and con-
as compared with HFL-1 cells; n ¼ 3 independent experiments.
Fig. 2. Effects of various kinase inhibitors on TNF-a-induced GM-CSF secretion and
TNF-a-induced CREB and p38 MAPK phosphorylation in HFL-1 cells. (A) Cells were
starved for 24 h, and inhibitors (30 mM PD98059, 10 mM SP600125, 10 mM SB239063,
and 10 mM LY294002) were added 10 min prior to TNF-a-stimulation. The cells were
cultured for 24 h, and the supernatants were centrifuged and subjected to ELISA. (B)
Time course of phosphorylation of various kinases and CREB by TNF-a in HFL1 cells.
The cells were starved for 24 h and stimulated with 10 ng/mL TNF-a for the indicated
times. (C) Effects of MAPK inhibitors on p38 MAPK and CREB phosphorylation in HFL-
1 cells. The cells were starved for 24 h and kinase inhibitors were added 10 min prior to
stimulation with 10 ng/mL TNF-a. Cells were further incubated for 10 min, and western
blot analysis was carried out using phosphorylation-speciﬁc antibodies. * P < 0.05, **
P < 0.0001 as compared with medium alone; n ¼ 4 independent experiments.
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Statistical analysis
Statistical analyses were performed using GraphPad Prism
software, version 6 (GraphPad Software, San Diego, CA, USA). All
values were expressed as the means ± standard errors of the means
(SEMs) from the indicated number of experiments. The data were
compared using the Student's t-tests for multiple comparisons.
Differences with P values of 0.05, after adjustment for the number
of comparisons, were considered statistically signiﬁcant.
Results
TNF-a-induced GM-CSF secretion from human lung ﬁbroblasts
First, we examined TNF-a-induced GM-CSF secretion using
airway structural cells. As shown in Figure 1A, HFL-1 cells exhibited
increased secretion of GM-CSF after TNF-a stimulation. Airway
structural cells did not show signiﬁcant GM-CSF secretion without
TNF-a stimulation. Moreover, GM-CSFmRNA expressionwas higher
in HFL-1 cells than in BEAS-2B human bronchial epithelial cells
(Fig. 1B). Next, we examined the mechanisms of GM-CSF secretion
using HFL-1 cells. TNF-a-induced GM-CSF secretion from HFL-
1 cells occurred in a concentration- and time-dependent manner
(Fig. 1C, D). Accordingly, we used 10 ng/mL TNF-a for 24 h, as
previously reported in human pulmonary epithelial cells.10
TNF-a-induced GM-CSF secretion and CREB phosphorylation by p38
MAPK in HFL-1 cells
To elucidate the mechanism of TNF-a-induced GM-CSF secretion,
we examined the effects of various MAPK inhibitors and PI3-K in-
hibitors on TNF-a-induced GM-CSF secretion. TNF-a-induced GM-
CSF secretion was partially inhibited by PD98059 (an ERK inhibi-
tor), SB239063 (a p38 MAPK inhibitor) and LY294002 (a PI-3 kinase
inhibitor), as shown in Figure 2A. To determine the time course of
this phosphorylation event after TNF-a stimulation, we performed
western blot analysis using phosphorylation-speciﬁc antibodies.
TNF-a stimulated the phosphorylation of p38 MAPK (Fig. 2B). p38
MAPK has also been shown to phosphorylate CREB at Ser133 in
human vascular smooth muscle cells.24 Consistent with this, TNF-a
stimulation also induced the phosphorylation of CREB in a pattern
similar to those of p38 MAPK phosphorylation (Fig. 2B). To further
investigate whether CREB phosphorylation was mediated by p38
MAPK in HFL-1 cells, we examined CREB phosphorylation after TNF-
a stimulation in the presence of the p38 MAPK inhibitor, SB239063.
As shown in Figure 2C, TNF-a-induced CREB phosphorylation was
completely inhibited by treatment with SB239063. Thus, we next
focused on the role of CREB in TNF-a-induced GM-CSF secretion.
The effects of cAMP and cAMP-elevating agents on TNF-a-induced
GM-CSF secretion in HFL-1 cells
CREB has been shown to function downstream of protein kinase
A (PKA) signaling.15e17 Therefore, we next examined the effects of
cell-permeable 8-bromo-cAMP on TNF-a-induced GM-CSF secre-
tion. As shown in Figure 3A, TNF-a-induced GM-CSF secretion was
inhibited by cAMP in a concentration-dependent manner. The PKA
inhibitor H89 did not block TNF-a-induced GM-CSF secretion,
indicating that TNF-a stimulation did not activate PKA signaling.
Recently, the cAMP-elevating agent Roﬂumilast, a phosphodies-
terase (PDE)-4 inhibitors, has been developed for use in the treat-
ment of severe COPD.36,37 Therefore, we next tested the effects ofcAMP-elevating agents, including Roﬂumilast and Rolipram, on
TNF-a-induced GM-CSF secretion. Interestingly, both Roﬂumilast
and Rolipram partly inhibited TNF-a-induced GM-CSF secretion,
and forskolin, a potent cAMP-elevating agent, inhibited TNF-a-
mediated GM-CSF secretion in a concentration-dependent manner
(Fig. 3B). Since cAMP/PKA signaling is thought to phosphorylate
CREB at Ser133, we examined the effect of cell-permeable 8-
bromo-cAMP on CREB phosphorylation in HFL-1 cells. As shown
in Figure 3C, stimulation of cAMP did not signiﬁcantly increase
CREB phosphorylation in the absence of TNF-a. In the presence of
TNF-a, cAMP did not activate signiﬁcant CREB phosphorylation,
while cAMP inhibited TNF-a-induced GM-CSF secretion. The results
indicate that cAMP inhibits TNF-a-induced GM-CSF secretion
without changing CREB phosphorylation in HFL-1 cells.Knockdown of CREB inhibited TNF-a-induced GM-CSF secretion
from HFL-1 cells and AHLFs
To explore the role of CREB downstream of p38 MAPK signaling
after TNF-a stimulation, we examined the effects of CREB knock-
down on TNF-a-induced GM-CSF secretion using CREB-speciﬁc
siRNAs. All CREB siRNAs speciﬁcally knocked down CREB protein
expression (Fig. 4A). Moreover, knockdown of CREB expression
inhibited TNF-a-induced GM-CSF secretion (Fig. 4B). Importantly,
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transfection (Fig. 4C) indicating that the transfection procedures
were not cytotoxic. We further examined the effects of CREB
knockdown on IL-8 secretion in HFL-1 cells. TNF-a-induced IL-8
secretion was not inﬂuenced by transfection with CREB-speciﬁc
siRNA (Fig. 4D). Next, we examined TNF-a-induced GM-CSF
mRNA expression in HFL-1 cells after treatment with CREB siR-
NAs. CREB knockdown inhibited TNF-a-induced GM-CSF mRNA
expression as well as GM-CSF secretion, while CREB knockdown did
not inﬂuence TNF-a-induced IL-8 mRNA expression (Fig. 5AeC).
These results suggested that CREB regulated TNF-a-induced GM-
CSF secretion via p38 MAPK, and that cAMP signaling inhibited
TNF-a-induced GM-CSF secretion in human lung ﬁbroblasts.
Finally, we examined the effects of CREB siRNA on TNF-a-
induced GM-CSF secretion in AHLFs. AHLFs as well as HFL-1
exhibited increased GM-CSF and IL-8 secretion after TNF-a stimu-
lation. As shown in Figure 6A, CREB phosphorylation was induced
by TNF-a stimulation and inhibited by the p38 MAPK inhibitor,
SB239063. Knockdown of CREB was achieved by transfection with
CREB siRNA in AHLFs (Fig. 6B). Importantly, knockdown of CREB
inhibited TNF-a-induced GM-CSF secretion (Fig. 6C) and slightly
inhibited cell proliferation (Fig. 6D). However, CREB knockdown did
not affect IL-8 secretion (Fig. 6E).
Discussion
To date, the signaling molecules involved in mediating GM-CSF
secretion have not been identiﬁed well. In this study, we aimed to
elucidate the mechanisms regulating GM-CSF secretion. Our results
showed that CREB played a critical role in p38 MAPK-dependent,Fig. 3. Effects of cAMP and cAMP-elevating agents on TNF-a-induced GM-CSF secretion, and
and 8-bromo-cAMP or H-89 was added 10 min prior to stimulation. Cells were cultured for 2
were added 10 min prior to stimulation. The cells were cultured for 24 h with 10 ng/mL TN
starved for 24 h and cell-permeable 8-bromo-cAMP was added in the absence of TNF-a as
15 min. Western blotting was used for detection of CREB phosphorylation. * P < 0.05, ** P
experiments.TNF-a-induced GM-CSF secretion, providing important insights
into these processes.
Although CREB has been shown to be activated by p38 MAPK
in previous studies in vascular endothelial and smooth muscle
cells,24,25 the physiological signiﬁcance of CREB activation by p38
MAPK remains unclear. Hashimoto et al. reported that p38 MAPK
regulates TNF-a-induced GM-CSF production in human bronchial
epithelial cells.10 Consistent with these ﬁndings, our results using
human lung ﬁbroblasts also revealed that the activity of p38
MAPK was particularly involved in TNF-a-induced GM-CSF
secretion. Although SB compounds, such as the inhibitor used
in this study, compete for the ATP binding of p38 MAPK and
inhibit signaling downstream of p38 MAPK, we observed partial
inhibition of TNF-a-induced p38 MAPK phosphorylation in our
study, consistent with the results of other studies.24 This effect
may be explained by reduced autophosphorylation of p38 MAPK
upon treatment with the SB compound.38,39 On the other hand,
p44/42 MAPK and AKT inhibitors partially blocked TNF-a-
induced GM-CSF secretion without affecting CERB phosphoryla-
tion. PD98059 and LY294002 which are thought to be speciﬁc
kinase inhibitors of p44/42 MAPK and PI-3 kinase, respectively.
Previous studies reported that PD98059 inhibits MEK5/ERK540
and cyclooxygenase 2,41 while LY294002 inhibits Pim-1 ki-
nase.42 Since TNF-a did not stimulate both p44/42 MAPK and AKT
phosphorylation in HFL-1 cells, other kinases affected by these
kinase inhibitors may be involved in the TNF-a-induced GM CSF
secretion. However, further investigations are needed.
Inhibition of GM-CSF secretion in airway structural cells may be
an important strategy for the treatment of asthma. In this study, we
examined the inhibitory mechanism of TNF-a-induced GM-CSFeffect of cAMP on CREB phosphorylatkon in HFL-1. (A) The cells were starved for 24 h
4 h with 10 ng/mL TNF-a. (B) The cells were starved for 24 h, and cAMP-elevating agents
F-a. The supernatants were centrifuged, and ELISA was carried out. (C) The cells were
indicated times. In the presence or absence of 8-bromo-cAMP, TNF-a was added for
< 0.0001, n.s., not signiﬁcant as compared with medium alone; n ¼ 5 independent
Fig. 4. Effect of CREB knockdown on TNF-a-induced GM-CSF and IL-8 secretion, and cytotoxicity in HFL-1 cells. (A) Knockdown of CREB by CREB-speciﬁc siRNA in HFL-1 cells. Cells
were transfected with CREB siRNA and starved for 24 h. Cells were then stimulated with 10 ng/mL TNF-a for 24 h, and western blotting was used for detection of CREB. (B) Effects of
CREB knockdown on TNF-a-induced GM-CSF secretion. Cells were transfected with CREB siRNA and starved for 24 h. The cells were stimulated with 10 ng/mL TNF-a for 24 h. The
supernatants were centrifuged, and ELISA was performed. (C) Effects of CREB siRNA on cell proliferation. Cell proliferation was evaluated using a Cell Counting Kit-8 after
transfection with CREB siRNA. (D) Effects of CREB knockdown on TNF-a-induced IL-8 secretion. Cells were transfected with CREB siRNA and starved for 24 h. Cells were then
stimulated with 10 ng/mL TNF-a for 24 h, and IL-8 secretion was measured by ELISA. * P < 0.0001, ** P < 0.05 as compared with nonsilencing siRNA, n.s., not signiﬁcant as compared
with non-silencing siRNA, n ¼ 5 independent experiments.
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elevating agents, such as Rolipram, inhibit TNF-a-induced GM-CSF
secretion in human bronchial epithelial cells,8 the effects of this
inhibitor on human lung ﬁbroblasts had not been clariﬁed. Here, we
found that HFL-1 cells exhibited greater increases in GM-CSF pro-
duction than Beas-2B cells after TNF-a stimulation. The amount of
GM-CSF secretion from Beas-2B cells in this study was similar to
those in previous reports.8,10 In HFL-1 cells, cAMP-elevating agents,Fig. 5. Effect of CREB knockdown on TNF-a-induced GM-CSF and IL-8 mRNA expression in H
(C) mRNA expression. Cells transfected with CREB siRNA were cultured for 36 h and starv
harvested for mRNA puriﬁcation. The y-axis shows the relative ratio of GM-CSF (A), IL-8 (B)
expression. * P < 0.05, ** P < 0.01, n.s., not signiﬁcant as compared with medium alone; nsuch as forskolin, Rolipram, and Roﬂumilast, inhibited TNF-a-
induced GM-CSF secretion. The inhibitory effects of these cAMP-
elevating agents on TNF-a-induced GM-CSF secretion were
similar to those described in previous reports.8,43 These results
indicated that cAMP signaling is an important inhibitory mecha-
nism for GM-CSF secretion.
CREB is a target in the cAMP signaling pathway15e17 and can also
be targeted by other kinases, including p38 MAPK.44 However,FL-1 cells. Effects of CREB knockdown on TNF-a-induced GM-CSF (A), IL-8 (B) and CREB
ed for 24 h. The cells were stimulated with 10 ng/mL TNF-a for 12 h. The cells were
and CREB (C) mRNA expression after TNF-a stimulation divided by the GAPDH mRNA
¼ 5 independent experiments.
Fig. 6. Effects of CREB knockdown on TNF-a-induced GM-CSF secretion and cytotoxicity in AHLFs. (A) Effects of MAPK inhibitors on p38 MAPK and CREB phosphorylation in AHLFs.
Cells were starved for 24 h, and kinase inhibitors were added 10 min prior to the stimulation with 10 ng/mL TNF-a. Cells were further incubated for 10 min, and phosphorylation
levels were measured by western blotting. (B) Knockdown of CREB using CREB siRNA in AHLFs. Cells were incubated with CREB siRNA, starved for 24 h, and then stimulated with
10 ng/mL TNF-a for 24 h. CREB expression was analyzed by western blotting. (C) Effects of CREB knockdown on TNF-a-induced GM-CSF secretion. Cells were incubated with CREB
siRNA, starved for 24 h, and stimulated with 10 ng/mL TNF-a for 24 h. GM-CSF secretionwas then analyzed by ELISA. (D) Effects of CREB siRNA on cell proliferation. Cell proliferation
was evaluated using a Cell Counting Kit-8 after transfection with CREB siRNA. (E) Effects of CREB knockdown on TNF-a-induced IL-8 secretion. Cells were transfected with CREB
siRNA, starved for 24 h, and stimulated with 10 ng/mL TNF-a for 24 h. IL-8 secretion was then assessed by ELISA. * P < 0.0001, ** P < 0.05, n.s., not signiﬁcant as compared with
nonsilencing siRNA; n ¼ 5 independent experiments.
Y. Koga et al. / Allergology International 65 (2016) 406e413412because of the opposing effects of cAMP and p38 MAPK on TNF-a-
induced GM-CSF secretion, the mechanisms mediating CREB
signaling after TNF-a stimulation are unclear. Our results of the
time-dependent effects of TNF-a stimulation on CREB and p38
MAPK phosphorylation supported that TNF-a-dependent CREB
phosphorylation was induced through p38 MAPK signaling rather
than cAMP signaling; thus, CREB upregulated TNF-a-induced GM-
CSF secretion. This may be a possible mechanism explaining the
increased CREB phosphorylation in the submucosa, where pulmo-
nary ﬁbroblasts are present, in patients with asthma,20 and inhib-
itory effect of cAMP/PKA pathway on TNF-a-induced GM-CSF
secretion may be caused by CREB phosphorylation at another site
or the blockage in the downstream of CREB phosphorylation in
HFL-1 cells. Further investigations are required to support these
hypotheses.
In summary, our results showed that p38 MAPK was essential
for TNF-a-induced GM-CSF secretion. Furthermore, the activation
of CREB was critical for intracellular regulation of GM-CSF secre-
tion. This study also demonstrated that cAMP-elevating agents had
inhibitory effects of TNF-a-induced GM-CSF secretion. Therefore,
inhibition of the p38 MAPK and CREB pathways may attenuate
eosinophilic inﬂammation and may have applications in the pre-
vention or treatment of asthma. Further studies of the signal
pathways activated by various cytokines may yield deeper insights
into the signaling mechanisms mediating GM-CSF secretion.
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